SEC 13F Intelligence

Exome Asset Management LLC / RGNX

Exome Asset Management LLC’s Regenxbio Inc Position

Does Exome Asset Management LLC own Regenxbio Inc (RGNX)? Not currently — the last reported position was 226.1K shares worth $2M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q2 2025
Shares
226.1K
% of Portfolio
+1.38%
Quarters Held
3
position exited

Position History RGNX

Reported value by quarter
Q1 ’24: $2MQ1 ’24Q1 ’25: $3MQ1 ’25Q2 ’25: $2MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025226.1K$2M+1.38%
Q1 2025405.3K$3M+2.58%
Q1 202484.5K$2M+1.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Exome Asset Management LLC’s full portfolio or all institutional holders of RGNX.